Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 22,854 | 2,222 | 1,089 | 1,849 | 4,908 |
| Gross Profit | 22,854 | 2,222 | 1,089 | 1,849 | 4,908 |
| Operating Expenses | 123,220 | 104,593 | 109,504 | 115,944 | 100,626 |
| Operating Income | -100,366 | -102,371 | -108,415 | -114,095 | -95,718 |
| Interest Expense | 2,253 | 1,971 | 2,114 | 2,528 | 2,719 |
| Other Income | 2,255 | 216 | 318 | 408 | -3,364 |
| Pre-tax Income | -100,364 | -104,126 | -110,211 | -116,215 | -101,801 |
| Income Tax | N/A | N/A | N/A | N/A | -26 |
| Net Income Continuous | -100,364 | -104,126 | -110,211 | -116,215 | -101,775 |
| Net Income | $-100,364 | $-104,126 | $-110,211 | $-116,215 | $-101,775 |
| EPS Basic Total Ops | -1.31 | -1.42 | -1.61 | -2.38 | -2.38 |
| EPS Basic Continuous Ops | -1.31 | -1.42 | -1.57 | -2.39 | -2.35 |
| EPS Diluted Total Ops | -1.31 | -1.42 | -1.61 | -2.38 | -2.38 |
| EPS Diluted Continuous Ops | -1.31 | -1.42 | -1.57 | -2.39 | -2.35 |
| EBITDA(a) | $-98,338 | $-99,508 | $-104,225 | $-109,208 | $-86,367 |